Hepatocyte growth factor enhances MMP activity in human endothelial cells.
暂无分享,去创建一个
J. Keiser | H Wang | J A Keiser | H. Wang | He Wang | Joan A. Keiser
[1] G. Camussi,et al. In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[2] J. Isner,et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.
[3] L. Liotta,et al. Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Matsumori,et al. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. , 1997, Circulation.
[5] Morag Park,et al. Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells Requires Phosphatidylinositol 3-Kinase (*) , 1995, The Journal of Biological Chemistry.
[6] F. Kikkawa,et al. c‐Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells , 1997, FEBS letters.
[7] J. Keiser,et al. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. , 1998, Circulation research.
[8] Itzhak D. Goldberg,et al. Regulation of Angiogenesis , 1996, Experientia Supplementum.
[9] E. Scanziani,et al. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. , 1995, Journal of the National Cancer Institute.
[10] S. Weiss,et al. Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*) , 1996, The Journal of Biological Chemistry.
[11] Y. Taniyama,et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. , 1999, Hypertension.
[12] L. Jin,et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[13] T. Nakamura,et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[14] A. Bardelli,et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.
[15] L. Naldini,et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.
[16] D. W. Vinter,et al. Purified Scatter Factor Stimulates Epithelial and Vascular Endothelial Cell Migration , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[17] T. Haas,et al. Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[18] E. Goldsmith,et al. How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.
[19] A. Bardelli,et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.
[20] E. Rosen,et al. Regulation of angiogenesis by scatter factor. , 1997, EXS.
[21] J. Rubin,et al. Mechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production* , 1996, The Journal of Biological Chemistry.
[22] E. Bauer,et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.
[23] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[24] W. Stetler-Stevenson,et al. MMP-2: expression, activation and inhibition. , 1996, Enzyme & protein.
[25] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[26] J. Keiser,et al. Expression of Membrane-Type Matrix Metalloproteinase in Rabbit Neointimal Tissue and Its Correlation with Matrix-Metalloproteinase-2 Activation , 1998, Journal of Vascular Research.
[27] M. Moses. The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors , 1997 .
[28] D. Cheresh,et al. Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.
[29] L. Cornelius,et al. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. , 1995, The Journal of investigative dermatology.
[30] L. Orci,et al. Tumor-promoting phorbol esters induce angiogenesis in vitro , 1985, Cell.